Connect with us

Marijuana Stocks

Green Growth Brands Officially Completes First Equity Raise Since Going Public

Published

on

Green Growth Brands Officially Completes First Equity Raise Since Going Public

Company dedicated to producing CBD and cannabis-focused experiences, Green Growth Brands announced on Thursday, August 22, 2019 that it had completed its first equity raise as a public company since October 2018 RTO.

This “bought deal financing” amounts to C$50,225,000, which according to the CEO, Peter Horvath will be combined with $102.7 million “backstop commitment”. The latter was led by Schottenstein family, which Horvath deems will support the firm in bringing innovative, CBD experiences.

Each of the Company’s shares were sold at a unit price of C$2.45, with a total of 20,500,000 units sold. Hemp Industry Daily also reported on this matter and elaborated more on how the funds raised will be allotted.

As it turns out, they will cover up the cash purchase price of the Nevada Organic Remedies’ acquisition, the Henderson Organic Remedies’ acquisition, deferred cash compensation and other fees related to the Spring Oaks Greenhouses acquisition and finally, capital expenditures among others.

Continue Reading

Ultimate CBD Guide


Disclaimer

ultimate-cbd-products-company-guidepopular-cbd-health-benefits best-cannabidiol-guide-resources hemp guide

TimesofCBD is the most active daily CBD news publication featuring the latest cannabis industry stories and marijuana market trends. As the leader in CBD-centric content curation, we invite all readers to come for the headlines and stay for the insights. Quality is the top priority when presenting user guides, analyzing product reviews and reporting fact-checked news announcements. All information is for educational and informational purposes only. Disclaimer.

Got news? Email contact@timesofcbd.com

Copyright © 2020 TimesofCBD.com | Latest CBD News, Cannabis Guides and Marijuana Trends
Note: Always seek real additional medical advice and consultation with a professional healthcare practitioner before considering any CBD. No statements found on this website have underwent Food and Drug Administration evaluation. The efficacy of any products or claims made have never been approved by the FDA either. No products shall ever be intended to diagnose, treat or cure any disease or prevent any ailment.